Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?

scientific article published on 23 June 2017

Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign? is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.3350/CMH.2017.0106
P932PMC publication ID5497669
P698PubMed publication ID28669139

P50authorNae-Yun HeoQ88432246
P2093author name stringNae-Yun Heo
P2860cites workLONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONQ58236604
The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis BQ84544446
EASL clinical practice guidelines: Management of chronic hepatitis B virus infectionQ29615868
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Q30391932
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B.Q33872988
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.Q34500537
AASLD guidelines for treatment of chronic hepatitis B.Q34501660
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.Q34785683
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapyQ35597901
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Q37384895
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.Q40245246
Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.Q42234528
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.Q42541246
Long-term safety of lamivudine treatment in patients with chronic hepatitis B.Q44729211
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.Q46217486
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.Q46575199
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.Q46981468
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectL-alanineQ218642
chronic hepatitis BQ55779876
P304page(s)125-127
P577publication date2017-06-23
P1433published inClinical and molecular hepatologyQ26853927
P1476titleIs alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
P478volume23